Related Experiment Video
Updated: Aug 10, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Expression of TREM-1 mRNA in acute pancreatitis
Da-Yu Wang1, Ren-Yi Qin, Zheng-Ren Liu
1Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.
Aim:
To explore the expression of triggering receptor expressed on myeloid cells (TREM-1) mRNA in acute pancreatitis (AP).
Methods:
Using the reverse transcription polymerase chain reaction (RT-PCR), we examined the expression of TREM-1 mRNA in 10 cases of mild acute pancreatitis (MAP), 8 cases of severe acute pancreatitis (SAP), and 10 cases of healthy control subjects. And we also examined the expression of TREM-1 mRNA in 14 cases of AP (including 10 MAP and 4 SAP) before treatment, after successful therapy and clinically cured.
Results:
The expression of TREM-1 mRNA in the groups of MAP, SAP patients and healthy control subjects was 0.771+/-0.274, 1.092+/-0.331 and 0.459+/-0.175, respectively; there was a significant difference among the three groups (P<0.05). And there was also a significant difference between the AP patients (0.914+/-0.341) and healthy control subjects (0.459+/-0.175) (P<0.05). Moreover, in the 14 cases of AP, before treatment, after successful therapy and clinically cured, the expression of TREM-1 mRNA was 0.905+/-0.226, 0.739+/-0.169 and 0.633+/-0.140, respectively, and there was a significant difference among the three stages (P<0.05).
Conclusion:
The expression of TREM-1 mRNA in the patients with AP increases obviously, and correlates with the degree of AP. Furthermore, the expression of TREM-1 mRNA is distinctly different at the different stages of AP. It indicates TREM-1 may play an important role in the occurrence and development of AP.
Insights
Triggering receptor expressed on myeloid cells (TREM-1) mRNA levels are elevated in acute pancreatitis (AP) and correlate with disease severity. TREM-1 expression changes significantly during AP progression and treatment, suggesting its role in the condition.
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Acute pancreatitis (AP) is a serious inflammatory condition of the pancreas.
- The role of immune receptors in AP pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the messenger RNA (mRNA) expression levels of triggering receptor expressed on myeloid cells (TREM-1) in patients with acute pancreatitis.
- To determine the correlation between TREM-1 mRNA expression and the severity and clinical stages of AP.
Main Methods:
- Reverse transcription polymerase chain reaction (RT-PCR) was employed to quantify TREM-1 mRNA expression.
- Expression levels were analyzed in three groups: mild AP (MAP), severe AP (SAP), and healthy controls.
- TREM-1 mRNA was also assessed in AP patients at different stages: before treatment, after successful therapy, and after clinical cure.
Main Results:
- TREM-1 mRNA expression was significantly higher in both MAP and SAP patients compared to healthy controls (P<0.05).
- Expression levels showed a significant difference among MAP, SAP, and control groups.
- A significant decrease in TREM-1 mRNA expression was observed as AP progressed from before treatment to successful therapy and clinical cure (P<0.05).
Conclusions:
- TREM-1 mRNA expression is significantly upregulated in acute pancreatitis.
- TREM-1 mRNA levels correlate with the severity and clinical stages of AP.
- These findings suggest that TREM-1 plays a crucial role in the development and progression of acute pancreatitis.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction